
IIT Guwahati has secured two Indian patents for a pioneering insulin production system that could dramatically reduce costs and improve accessibility for millions of diabetes patients.
What’s the Innovation?
- Developed a novel bioprocess using Pseudomonas fluorescens, a safe and efficient bacterial system.
- Unlike traditional methods using E. coli, this system yields soluble insulin, simplifying production.
- Leverages Genetic, Metabolic, and Biochemical Engineering to optimize output and safety.
Key Advantages
- Lower production costs
- Higher yield of usable insulin.
- Potential to produce other therapeutic proteins and industrial enzymes using the same system.
Patent Details
| Patent No. | Application No. | Date of Grant |
|---|---|---|
| 568947 | 202431045821 | 22 July 2025 |
| 536416 | 202331058235 | 01 May 2024 |
Research Team
- Prof. Veeranki Venkata Dasu (Lead)
- Ansuman Sahoo (PMRF Scholar)
- Prabir Kumar Das
- Dr. MSRC Murthy
- Prof. Sanjukta Patra







IndianWeb2.com is an independent digital media platform for business, entrepreneurship, science, technology, startups, gadgets and climate change news & reviews.